{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:22:33Z","timestamp":1698499353947},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":4546,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1995,10]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> In a prospective open\u2010labelled phase I\/II trial we tested efficacy and tolerability of recombinant human interleukin\u20103 (rhIL\u20103) alone in patients with refractory severe aplastic anaemia (SAA). 15 patients with idiopathic (12 patients) or secondary (one post\u2010hepatitic, one drug induced, one dyskeratosis congenita) SAA, refractory or relapsing after one to three courses of antilymphocyte globulin were included. 14 patients were transfusion dependent (RBC 14, platelet 12). RhIL\u20103 was planned for three patients each at five escalating dose levels of 1, 2, 4, 8 and 16pg\/kg, given daily as 24 h continuous infusion for 21 d. RhIL\u20103 was prematurely withdrawn at days 10 and 11 for adverse events in two patients. 9\/15 patients showed an increase in WBC; 2\/6 at the 1\u20102 <jats:italic>\u03bc<\/jats:italic>g\/kg and 7\/9 at the 4\u201016 \u03bcg\/kg level, but no sustained effects were seen. No patient showed a response in platelet counts. Additionally, platelet and RBC transfusion requirements were unchanged pre and post study. All patients experienced one or more adverse event, mainly fever (15 patients), bleeding (nine patients), and headache (six patients). Occurrence of adverse events was dose related and the maximum tolerated dose was reached with 8 \u03bcg\/kg. Five patients suffered serious adverse events. RhIL\u20103 as single growth factor and used alone is of minimal benefit in severe aplastic anaemia.<\/jats:p>","DOI":"10.1111\/j.1365-2141.1995.tb05294.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T11:15:44Z","timestamp":1205320544000},"page":"306-312","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recombinant human interleukin\u20103 in refractory severe aplastic anaemia: a phase I\/II trial"],"prefix":"10.1111","volume":"91","author":[{"given":"Mario J.","family":"Bargetzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Gldckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Tichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Devergie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Esperou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Wodnar\u2010Filipowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Speck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alois","family":"Gratwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.705.705"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.11.3871"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198301203080301"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3051378"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241901"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.10.2583.2583"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.7.1287.1287"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.4.666.666"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.3.455.455"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-3-223"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V79.5.1155.1155","article-title":"In vivo synergism of recombinant human interleukin\u20103 and recombinant human interleukin\u20106 on thrombopoiesis in primates","volume":"79","author":"Geissler K.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.V75.12.2305.2305","article-title":"Recombinant human interleukin\u20103 expands the pool of circulating hematopoietic progenitor cells in primates: synergism with recombinant human granulocyte\/macrophage colony\u2010stimulating factor","volume":"75","author":"Geissler K.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.2.302.302"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01703450"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Hurwitz N. Probst A. Zufferey G. Tichelli A. Pless M. Kappos L. Speck B. &Gratwohl A.(1996)Fatal vascular leak syndrome with extensive hemorrhage peripheral neuropathy and reactive erythrophagocytosis: an unusual complication of recombinant IL\u20103 therapy.Leukemia and Lymphoma(in press).","DOI":"10.3109\/10428199609051628"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood.V77.5.937.937","article-title":"Treatment of aplastic anaemia in children with recombinant granulocyte colony\u2010stimulating factor","volume":"77","author":"Kojima S.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_19_1","first-page":"2964","article-title":"In vivo effects of recombinant human colony stimulating factors on hematopoiesis in cynamolgus monkeys","volume":"21","author":"Krumwieh D.","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.7.1241"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood.V70.5.1343.1343","article-title":"Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte\u2010macrophage colony\u2010stimulating factor","volume":"70","author":"Leary A.G.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92763-4"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.2.613.613"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01695887"},{"key":"e_1_2_1_25_1","first-page":"875","article-title":"A phase I\/II study of interleukin\u20103 in patients with aplastic anemia and myelodysplasia","volume":"22","author":"Nimer S.D.","year":"1994","journal-title":"Experimental Hematology"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb08288.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.6.2045.2045"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V72.5.1580.1580","article-title":"Effects of recombinant human interleukin\u20103 on CD34\u2010enriched normal hematopoietic progenitors and on myeloblastic leukemia cells","volume":"72","author":"Saeland S.","year":"1988","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_29_1","article-title":"Phase I trials of interleukin\u20106 (IL\u20106) in patients with advanced renal cell carcinoma (RCC) and patients with aplastic anemia (AA): effects of long\u2010term application and differences of hemopoietic response to IL\u20106 in patients with normal hemopoiesis versus patients with aplastic anemia","volume":"82","author":"Schrezenmeier H.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.12.4360"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91537-9"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb06723.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V74.5.1571.1571","article-title":"Effects of interleukin\u20103 and erythropoietin on in vivo erythropoiesis and F\u2010cell formation in primates","volume":"74","author":"Umemura T.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812223192503"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06408.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1995.tb05294.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1995.tb05294.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:05:05Z","timestamp":1698365105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1995.tb05294.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["10.1111\/j.1365-2141.1995.tb05294.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb05294.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}